PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium ProgramLing Li, Ken H. Young, Hua You et al.|Modern Pathology|2019Cited by 55
Quantitative Multiplexed Immunohistochemistry Assays for Exploring CAR Modified T Cells and Checkpoint Inhibitors in Lymphoma TrialsThai H. Tran, Naveen Dakappagari, Krupa Scott et al.|Blood|2015Cited by 2
Predictive evaluation of quantitative spatial profiling of the tumor microenvironment by multiplex immunofluorescence in recurrent glioblastoma treated with PD-1 inhibitors.David Cieremans, Fábio M. Iwamoto, Ju‐Young Kim et al.|Journal of Clinical Oncology|2020Cited by 1
Predictive Evaluation of Quantitative Spatial Profiling of the Tumor Microenvironment by Multiplex Immunofluorescence in Recurrent Glioblastoma Treated with PD-1 InhibitorsDavid Cieremans, Fábio M. Iwamoto, Ju‐Young Kim et al.|Research Square|2021Cited by 1
Abstract 2754: Exploring the interplay between TAM, PD-L1 and immunosuppressive molecules by a novel multiplex immunofluorescence assay in cancer immunotherapy trialsLisa Adams, Jennifer Bordeaux, Deepika K. Asnani et al.|Cancer Research|2021Cited by 0